These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 16141683)

  • 1. Sivelestat, a neutrophil elastase inhibitor, reduces mortality rate of critically ill patients.
    Hoshi K; Kurosawa S; Kato M; Andoh K; Satoh D; Kaise A
    Tohoku J Exp Med; 2005 Oct; 207(2):143-8. PubMed ID: 16141683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients.
    Miyoshi S; Ito R; Katayama H; Dote K; Aibiki M; Hamada H; Okura T; Higaki J
    Drug Des Devel Ther; 2014; 8():1211-9. PubMed ID: 25214765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection.
    Tsujii S; Okabayashi T; Shiga M; Takezaki Y; Sugimoto T; Kobayashi M; Hanazaki K
    World J Surg; 2012 May; 36(5):1122-1127. PubMed ID: 22366983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative analysis of sivelestat sodium hydrate and ulinastatin combination therapy in the treatment of sepsis with acute respiratory distress syndrome.
    Xu J; Zhang C; Wu K; Qian Y; Hu W
    BMC Pulm Med; 2024 Jun; 24(1):283. PubMed ID: 38886709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-alpha.
    Wada Y; Yoshida K; Hihara J; Konishi K; Tanabe K; Ukon K; Taomoto J; Suzuki T; Mizuiri H
    Cancer Sci; 2006 Oct; 97(10):1037-43. PubMed ID: 16918998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effects of neutrophil elastase inhibitor on gastrointestinal dysfunction in sepsis.
    Sun JK; Li JJ; Deng YH; Yin X; Huangfu XT; Ye ZY; Zhou XH; Chen YM; Yuan ST; Wang X
    Clin Transl Sci; 2024 May; 17(5):e13829. PubMed ID: 38769746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome.
    Matera MG; Rogliani P; Ora J; Calzetta L; Cazzola M
    Expert Opin Investig Drugs; 2023; 32(9):793-802. PubMed ID: 37740909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sivelestat (Neutrophil Elastase Inhibitor) as an Anti-inflammatory and Anti-viral Agent: An In Silico Study.
    Rajagopal D; Narayanaswamy R; Prabhakaran VS
    Cureus; 2024 Mar; 16(3):e56846. PubMed ID: 38659558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors.
    Crocetti L; Giovannoni MP; Cantini N; Guerrini G; Vergelli C; Schepetkin IA; Khlebnikov AI; Quinn MT
    Front Chem; 2020; 8():795. PubMed ID: 33033716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of appropriate indications for the use of sivelestat sodium in acute respiratory distress syndrome: a retrospective cohort study.
    Maki C; Inoue Y; Ishihara T; Hirano Y; Kondo Y; Sueyoshi K; Okamoto K; Tanaka H
    Acute Med Surg; 2020; 7(1):e471. PubMed ID: 31988783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological agents for adults with acute respiratory distress syndrome.
    Lewis SR; Pritchard MW; Thomas CM; Smith AF
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004477. PubMed ID: 31334568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis.
    Iwata K; Doi A; Ohji G; Oka H; Oba Y; Takimoto K; Igarashi W; Gremillion DH; Shimada T
    Intern Med; 2010; 49(22):2423-32. PubMed ID: 21088343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness of sivelestat in treating sepsis patients with both acute respiratory distress syndrome and septic cardiomyopathy.
    Lv H; Huang L; Yang X; Zhang C; Yu H; Shang X
    J Cardiothorac Surg; 2024 Jun; 19(1):399. PubMed ID: 38937755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy Analysis and Prognostic Impact of Sivelestat Sodium in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome.
    Che X; Hu W; Zhang Z; Wang L; Xu Z; Wang F
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sivelestat sodium for treatment of patients with COVID-19-associated acute respiratory distress syndrome in intensive care unit: a single-center retrospective cohort study].
    Luo M; Hu H; Sun Y; Zhao X; Zeng Z; Liu Y; Wu G
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1259-1267. PubMed ID: 37712261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic acute respiratory distress syndrome: A narrative review on pathophysiology and treatment.
    Malek M; Hassanshahi J; Fartootzadeh R; Azizi F; Shahidani S
    Chin J Traumatol; 2018 Feb; 21(1):4-10. PubMed ID: 29398292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Pulmonary Edema after Minimally Invasive Cardiac Surgery with Mini-Thoracotomy Using Neutrophil Elastase Inhibitor.
    Yamashiro S; Arakaki R; Kise Y; Kuniyoshi Y
    Ann Thorac Cardiovasc Surg; 2018 Feb; 24(1):32-39. PubMed ID: 29118307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil elastase and its therapeutic effect on leukemia cells.
    Jiang KL; Ma PP; Yang XQ; Zhong L; Wang H; Zhu XY; Liu BZ
    Mol Med Rep; 2015 Sep; 12(3):4165-4172. PubMed ID: 26081156
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.